Exposure to violence takes a toll on the socioemotional well-being of Californians

Researchers at the UC Davis Violence Prevention Research Program (VPRP) assessed the prevalence of exposure to violence, such as robbery or assault, and its impacts on the mental health and social functioning of California adults. Their study, published in the Journal of Interpersonal Violence, shows the far-reaching psychological effects an incident of gun violence can […]

Continue Reading

New PTSD biotypes enables improved tests, sheds light on divergent treatments efficacy

Researchers from the PTSD Systems Biology Consortium, led by scientists from the Walter Reed Army Institute of Research, have identified distinct biotypes for post-traumatic stress disorder, the first of their kind for any psychological disorder. “These biotypes can refine the development of screening tools and may explain the varying efficacy of PTSD treatments,” said Dr. […]

Continue Reading

The role of T cells in fighting cancer

New research from CU Cancer Center member Jing Hong Wang, MD, Ph.D., and recent University of Colorado Immunology program graduate Rachel Woolaver, Ph.D., may help researchers develop more effective personalized immunotherapy for cancer patients. Working within Wang’s specialty of cancer immunology and head and neck squamous cell carcinomas (HNSCCs), the researchers worked to establish a […]

Continue Reading

Study demonstrates efficacy of new treatment for neurofibromatosis type 1-related tumors

Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers at Children’s Hospital of Philadelphia (CHOP) as part of the Neurofibromatosis Clinical Trials Consortium have shown that the drug, cabozantinib, reduces tumor volume and pain in patients with the genetic disorder neurofibromatosis type 1 (NF1). The results of the Phase 2 […]

Continue Reading

Researchers discover new inhibitor drug combination for rare form of cancer

Waldenstr√∂m macroglobulinemia (WM), a rare form of lymphoma, does not have any known cure and only one FDA-approved treatment making it challenging to treat patients. Researchers at the University of New Hampshire took the novel approach of targeting specific cell proteins that control DNA information using inhibitors, or drugs, that were effective in reducing the […]

Continue Reading

Unexplained 7-fold variation in euthanasia rates across the Netherlands

There’s a 7-fold unexplained variation in rates of euthanasia across The Netherlands, reveals an analysis of health insurance claims data, published online in the journal BMJ Supportive & Palliative Care. It’s not clear if these differences relate to underuse, overuse, or even misuse, say the researchers. The Netherlands was the first country in the world […]

Continue Reading